Gu Yu-Chen, Rao Mahendra S, Vemuri Mohan C
Stem Cells and Regenerative Medicine, Primary and Stem Cell Culture Systems, Life Technologies, 7335 Executive Way, Frederick, MD 21704, USA.
J Stem Cells. 2009;4(2):95-103.
Human umbilical cord blood (UCB) is a valuable alternative source of ethically acceptable, clinically competent stem cells that is most likely closest to embryonic stem cells. Development of reliable methods for the expansion of cord blood stem cells is critical to ensure their clinical application. In the present article, advances in cord blood stem cell isolation, culture expansion methods through co-culture with human mesenchymal stem cells, culture optimization techniques with defined media and cord blood stem cell banking aspects have been reviewed. Refined methods of isolation as well as defined culture conditions of expansion that favor retention of stem cell phenotype and proper cryogenic storage can significantly increase the use of cord blood stem cells in human cell therapy applications.
人脐带血(UCB)是一种宝贵的替代干细胞来源,在伦理上可接受,临床上具备应用能力,且极有可能最接近胚胎干细胞。开发可靠的脐带血干细胞扩增方法对于确保其临床应用至关重要。在本文中,对脐带血干细胞分离、通过与人间充质干细胞共培养进行培养扩增的方法、使用限定培养基的培养优化技术以及脐带血干细胞库方面的进展进行了综述。精细的分离方法以及有利于保留干细胞表型和适当低温保存的限定扩增培养条件,可显著增加脐带血干细胞在人类细胞治疗应用中的使用。